Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond
AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as ‘TB Consilium’. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for...
Saved in:
| Published in: | Pulmonology Vol. 24; no. 2; pp. 132 - 141 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
Spain
Taylor & Francis
01.03.2018
Taylor & Francis Group |
| Subjects: | |
| ISSN: | 2531-0437, 2531-0429, 2531-0437 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Abstract | AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as ‘TB Consilium’. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes – or managing the patients inappropriately, in order to improve their clinical outcomes. At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB. In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases. The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society – ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved. In addition a comparative analysis of the TB Consilia in the different countries has been performed. |
|---|---|
| AbstractList | As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as 'TB Consilium'. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes - or managing the patients inappropriately, in order to improve their clinical outcomes. At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB. In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases. The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society - ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved. In addition a comparative analysis of the TB Consilia in the different countries has been performed.As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as 'TB Consilium'. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes - or managing the patients inappropriately, in order to improve their clinical outcomes. At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB. In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases. The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society - ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved. In addition a comparative analysis of the TB Consilia in the different countries has been performed. As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as 'TB Consilium'. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes - or managing the patients inappropriately, in order to improve their clinical outcomes. At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB. In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases. The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society - ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved. In addition a comparative analysis of the TB Consilia in the different countries has been performed. AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as ‘TB Consilium’. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes – or managing the patients inappropriately, in order to improve their clinical outcomes. At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB. In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases. The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society – ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved. In addition a comparative analysis of the TB Consilia in the different countries has been performed. As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as ‘TB Consilium’. This body usually includes different medical specialities, competences and perspectives (e.g., clinical expertise both for adults and children; surgical, radiological and public health expertise; psychological background and nursing experience, among others), thus lowering the risk of making mistakes – or managing the patients inappropriately, in order to improve their clinical outcomes.At present, several high MDR-TB burden countries in the different WHO regions (and beyond) have introduced TB Consilium-like bodies at the national or subnational level to reach consensus on the best treatment approach for their patients affected by TB.In addition, in countries/settings where a formal system of consultation does not exist, specialized staff from MDR-TB reference centres or international organizations usually spend a considerable amount of their working time responding to phone or e-mail clinical queries on how to manage M/XDR-TB cases.The aim of this manuscript is to describe the different experiences with the TB Consilia both at the international level (European Respiratory Society – ERS/WHO TB Consilium) and in some of the countries where this experience operates successfully in Europe and beyond. The Consilium experiences are described around the following topics: (1) history, aims and focus; (2) management and funding; (3) technical functioning and structure; (4) results achieved.In addition a comparative analysis of the TB Consilia in the different countries has been performed. Keywords: MDR-TB, XDR-TB, Clinical management, Drug resistance, Prevention, Consilium |
| Author | Skrahina, A Tadolini, M Migliori, G.B Saavedra Herrera, N Guglielmetti, L Duarte, R Payen, M.C Muñoz Torrico, M D’Ambrosio, L Salazar Lezama, M.A Tiberi, S Veziris, N Bothamley, G Caminero Luna, J.A |
| Author_xml | – sequence: 1 fullname: D’Ambrosio, L – sequence: 2 fullname: Bothamley, G – sequence: 3 fullname: Caminero Luna, J.A – sequence: 4 fullname: Duarte, R – sequence: 5 fullname: Guglielmetti, L – sequence: 6 fullname: Muñoz Torrico, M – sequence: 7 fullname: Payen, M.C – sequence: 8 fullname: Saavedra Herrera, N – sequence: 9 fullname: Salazar Lezama, M.A – sequence: 10 fullname: Skrahina, A – sequence: 11 fullname: Tadolini, M – sequence: 12 fullname: Tiberi, S – sequence: 13 fullname: Veziris, N – sequence: 14 fullname: Migliori, G.B |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29229274$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-01981779$$DView record in HAL |
| BookMark | eNqFkU9v1DAQxSNUREvpN0DIRzhk8Z8kTnpAaquFVlqJA1uJmzWxJ62XrB3spGK_PQ5pEXBBGmlGT--9w_xeZkfOO8yy14yuGGXV-90qDINDt-KUySStKC2fZSe8FCynhZBHf9zH2VmMO0opTyNq9iI75g1PI4uT7HaLsCcwDMGDviejJ3twcIfE2K6zeurHfPT5GBBGsr0kGiLGc7L-MWCw6DRGYh1ZT8EPSMAZ0uLBO_Mqe95BH_HscZ9mtx_X26vrfPP5083VxSbXZcXGHNuaC65rKIqqqXVp2q7umraWHeuKumQ16HSYskQQCLrlWtCm4IYbEKKVRpxmN0uv8bBTQ7B7CAflwapfgg93CsJodY9Ksq6iKCuDjBad4S2vWSmqDtqmBcpY6nq3dN1D_1fV9cVGzRplTc2kbB5m79vFm972fcI4qr2NGvseHPopKtbIitJKlk2yvnm0Tu0eze_mJwTJcL4YdPAxBuyUtiOM1rsxgO0Vo2pGrnZqQa5m5LOakKdw8U_4qf8_sQ9LDBOcB4tB6d46q6H_hgeMOz8Fl7gppiJXVH3hTIqSsTKt1Cm-ip_fDsUa |
| CitedBy_id | crossref_primary_10_1183_23120541_00512_2022 crossref_primary_10_1111_resp_14559 crossref_primary_10_1016_j_pulmoe_2022_01_018 crossref_primary_10_1093_cid_ciac485 crossref_primary_10_1016_j_ijid_2019_01_040 crossref_primary_10_3389_fpubh_2019_00222 crossref_primary_10_3201_eid2809_220458 crossref_primary_10_1186_s12890_021_01597_1 crossref_primary_10_1177_11786361231152438 crossref_primary_10_1016_j_pulmoe_2018_01_002 crossref_primary_10_1016_j_pulmoe_2020_10_005 crossref_primary_10_5588_ijtldopen_24_0228 crossref_primary_10_1186_s13018_022_03372_2 crossref_primary_10_3390_app10062153 crossref_primary_10_7759_cureus_64586 crossref_primary_10_1183_16000617_0035_2018 |
| Cites_doi | 10.1183/09031936.00134712 10.1183/13993003.02049-2016 10.1183/13993003.02308-2016 10.1183/09031936.00043315 10.1183/09031936.00198813 10.1183/09031936.00214014 10.1183/13993003.01719-2016 10.1183/09031936.00216613 10.1183/09031936.00125813 10.1183/09031936.00203811 10.1183/13993003.00891-2017 10.1016/j.ijid.2014.12.024 10.5588/ijtld.11.0411 10.1183/09031936.00170411 10.1183/13993003.01799-2016 10.1183/09031936.00136312 10.1164/ajrccm.160.2.9901012 10.1183/09031936.00079413 10.1183/13993003.00424-2016 10.1183/09031936.00145411 10.1183/09031936.00196712 10.1183/09031936.00204611 |
| ContentType | Journal Article |
| Copyright | Sociedade Portuguesa de Pneumologia Copyright © 2017 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License |
| Copyright_xml | – notice: Sociedade Portuguesa de Pneumologia – notice: Copyright © 2017 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. – notice: Distributed under a Creative Commons Attribution 4.0 International License |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC VOOES DOA |
| DOI | 10.1016/j.rppnen.2017.10.005 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 2531-0437 |
| EndPage | 141 |
| ExternalDocumentID | oai_doaj_org_article_71f60e76de104fd2b281536fab9ba011 oai:HAL:hal-01981779v1 29229274 10_1016_j_rppnen_2017_10_005 1_s2_0_S217351151730163X |
| Genre | Journal Article Review |
| GeographicLocations | Europe |
| GeographicLocations_xml | – name: Europe |
| GroupedDBID | .1- .FO 1P~ 65R AACTN AAEDW AALRI AAXUO ABMAC ACLIJ ADBBV ADVLN AEXQZ AFCTW AFRHN AFTJW AITUG AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMRAJ BCNDV EBS EJD FDB GROUPED_DOAJ NCXOZ OK1 ROL SSZ TDBHL Z5R 0R~ AAYWO AAYXX ACVFH ADCNI AEUPX AFPUW AIGII AKBMS AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 1XC M4Z VOOES AQTUD |
| ID | FETCH-LOGICAL-c561t-eb8232c8a44698c5dbf8f9b87f1f48518ac1f4d55ea3eacb2c30942d2da33b7d3 |
| IEDL.DBID | DOA |
| ISICitedReferencesCount | 22 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000433491300009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 2531-0437 2531-0429 |
| IngestDate | Mon Nov 03 21:56:58 EST 2025 Tue Oct 14 20:38:44 EDT 2025 Thu Oct 02 06:03:48 EDT 2025 Thu Apr 03 06:59:44 EDT 2025 Sat Nov 29 08:05:31 EST 2025 Tue Nov 18 22:39:55 EST 2025 Tue Feb 25 19:56:23 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | Prevention MDR-TB Clinical management XDR-TB Drug resistance Consilium |
| Language | English |
| License | Copyright © 2017 Sociedade Portuguesa de Pneumologia. Published by Elsevier España, S.L.U. All rights reserved. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c561t-eb8232c8a44698c5dbf8f9b87f1f48518ac1f4d55ea3eacb2c30942d2da33b7d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://doaj.org/article/71f60e76de104fd2b281536fab9ba011 |
| PMID | 29229274 |
| PQID | 1976006759 |
| PQPubID | 23479 |
| PageCount | 10 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_71f60e76de104fd2b281536fab9ba011 hal_primary_oai_HAL_hal_01981779v1 proquest_miscellaneous_1976006759 pubmed_primary_29229274 crossref_citationtrail_10_1016_j_rppnen_2017_10_005 crossref_primary_10_1016_j_rppnen_2017_10_005 elsevier_clinicalkeyesjournals_1_s2_0_S217351151730163X |
| PublicationCentury | 2000 |
| PublicationDate | 2018-03-01 |
| PublicationDateYYYYMMDD | 2018-03-01 |
| PublicationDate_xml | – month: 03 year: 2018 text: 2018-03-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Spain |
| PublicationPlace_xml | – name: Spain |
| PublicationTitle | Pulmonology |
| PublicationTitleAlternate | Pulmonology |
| PublicationYear | 2018 |
| Publisher | Taylor & Francis Taylor & Francis Group |
| Publisher_xml | – name: Taylor & Francis – name: Taylor & Francis Group |
| References | e_1_3_2_27_1 e_1_3_2_28_1 e_1_3_2_29_1 D’Ambrosio L. (e_1_3_2_5_1) 2015; 7 e_1_3_2_20_1 e_1_3_2_21_1 e_1_3_2_22_1 e_1_3_2_23_1 e_1_3_2_24_1 e_1_3_2_25_1 e_1_3_2_26_1 e_1_3_2_16_1 e_1_3_2_9_1 e_1_3_2_17_1 e_1_3_2_8_1 e_1_3_2_18_1 e_1_3_2_7_1 e_1_3_2_19_1 e_1_3_2_2_1 e_1_3_2_31_1 e_1_3_2_30_1 e_1_3_2_10_1 e_1_3_2_11_1 e_1_3_2_32_1 e_1_3_2_6_1 e_1_3_2_12_1 e_1_3_2_13_1 e_1_3_2_4_1 e_1_3_2_14_1 e_1_3_2_3_1 e_1_3_2_15_1 |
| References_xml | – ident: e_1_3_2_22_1 – ident: e_1_3_2_3_1 doi: 10.1183/09031936.00134712 – ident: e_1_3_2_19_1 doi: 10.1183/13993003.02049-2016 – ident: e_1_3_2_28_1 – ident: e_1_3_2_11_1 doi: 10.1183/13993003.02308-2016 – ident: e_1_3_2_17_1 doi: 10.1183/09031936.00043315 – ident: e_1_3_2_16_1 doi: 10.1183/09031936.00198813 – ident: e_1_3_2_15_1 doi: 10.1183/09031936.00214014 – ident: e_1_3_2_26_1 doi: 10.1183/13993003.01719-2016 – ident: e_1_3_2_14_1 doi: 10.1183/09031936.00216613 – ident: e_1_3_2_7_1 doi: 10.1183/09031936.00125813 – ident: e_1_3_2_13_1 doi: 10.1183/09031936.00203811 – ident: e_1_3_2_32_1 – ident: e_1_3_2_25_1 doi: 10.1183/13993003.00891-2017 – ident: e_1_3_2_6_1 doi: 10.1016/j.ijid.2014.12.024 – ident: e_1_3_2_2_1 – ident: e_1_3_2_21_1 – ident: e_1_3_2_24_1 – ident: e_1_3_2_30_1 doi: 10.5588/ijtld.11.0411 – ident: e_1_3_2_12_1 doi: 10.1183/09031936.00170411 – ident: e_1_3_2_27_1 doi: 10.1183/13993003.01799-2016 – ident: e_1_3_2_4_1 doi: 10.1183/09031936.00136312 – ident: e_1_3_2_23_1 doi: 10.1164/ajrccm.160.2.9901012 – ident: e_1_3_2_31_1 – volume: 7 start-page: 1080 year: 2015 ident: e_1_3_2_5_1 article-title: A new free-cost e-service supporting clinicians to manage their difficult-to-treat TB cases: the ERS-WHO TB Consilium publication-title: J Thorac Dis – ident: e_1_3_2_9_1 doi: 10.1183/09031936.00079413 – ident: e_1_3_2_18_1 doi: 10.1183/13993003.00424-2016 – ident: e_1_3_2_20_1 doi: 10.1183/09031936.00145411 – ident: e_1_3_2_8_1 doi: 10.1183/09031936.00196712 – ident: e_1_3_2_10_1 doi: 10.1183/09031936.00204611 – ident: e_1_3_2_29_1 |
| SSID | ssj0002002381 ssib044757603 |
| Score | 2.220599 |
| SecondaryResourceType | review_article |
| Snippet | AbstractAs recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known... As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as 'TB... As recommended by the World Health Organization (WHO), optimal management of MDR-TB cases can be ensured by a multi-speciality consultation body known as ‘TB... |
| SourceID | doaj hal proquest pubmed crossref elsevier |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 132 |
| SubjectTerms | Adult Child Europe Human health and pathology Humans Infectious diseases Life Sciences Patient Care Team Pulmonology and respiratory tract Tuberculosis, Multidrug-Resistant - drug therapy |
| Title | Team approach to manage difficult-to-treat TB cases: Experiences in Europe and beyond |
| URI | https://www.clinicalkey.es/playcontent/1-s2.0-S217351151730163X https://www.ncbi.nlm.nih.gov/pubmed/29229274 https://www.proquest.com/docview/1976006759 https://hal.sorbonne-universite.fr/hal-01981779 https://doaj.org/article/71f60e76de104fd2b281536fab9ba011 |
| Volume | 24 |
| WOSCitedRecordID | wos000433491300009&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0002002381 issn: 2531-0437 databaseCode: DOA dateStart: 20180101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 2531-0437 dateEnd: 99991231 omitProxy: false ssIdentifier: ssib044757603 issn: 2531-0437 databaseCode: M~E dateStart: 20180101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZoVSEuiJZXgFYGcTUkdhIn3FrUqoe2QmKL9mb5KVqV7GqT9shvZ8ZOlu4B9YIURZHlOMl47JnJzHxDyMfS2MLlPmecG8HKIhfMWMNZ8GXpRAUSIuJ0_ziTFxfNfN5-u1fqC2PCEjxwItxnWYQ697J2HgyH4LjhDSzSOmjTGp2nrN5ctveMqevoXouyCCvLAZMxBPCZ8uZicNdquew8wp8W8lMM7qo25FKE798QT1s_MU7yX0poFEYnz8jTUYukh-ntd8kj3-2Rx-ejn_w5uZx5_YtOeOF0WNAUpUqxHkpE22DDgsUgczo7ohZEWf-F_oU97ulVR9OPeqo7R03Mc3lBLk-OZ19P2VhAgVlQiwbmTQMKk210iXUibeVMaEJrGhmKUOIsaAsXrqq8FrABG24FWHvccaeFMNKJl2S7W3T-NaEB1CRdodMQDBBRCQ3zkJcyCO9ybUWdETGRT9kRXRyLXNyoKYzsWiWiKyQ6tgLRM8LWdy0TusYD_Y9wZtZ9ERs7NgDHqJFj1EMckxE5zaua0k9hw_T9uHp7Vaieq1x9B3MN_axVgdtgLeYZ-QBssPH008MzhW2gKTeFlO0dDP9-4hIFSxX9L7rzi1sYtkUvKFhobUZeJfZZj8VbDocs3_yPL3xLngDRmhQq945sD6tbv0927N1w1a8OyJacNwdxvcD5_PfxH9plFRo |
| linkProvider | Directory of Open Access Journals |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Team+approach+to+manage+difficult-to-treat+TB+cases%3A+Experiences+in+Europe+and+beyond&rft.jtitle=Pulmonology&rft.au=D%27Ambrosio%2C+L&rft.au=Bothamley%2C+G&rft.au=Caminero+Luna%2C+J+A&rft.au=Duarte%2C+R&rft.date=2018-03-01&rft.issn=2531-0437&rft.eissn=2531-0437&rft.volume=24&rft.issue=2&rft.spage=132&rft_id=info:doi/10.1016%2Fj.rppnen.2017.10.005&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_m | http://cvtisr.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F25310437%2FS2531043718X00038%2Fcov150h.gif |